Annual Congress Munich 2006

Saturday, 02.09.2006
Sunday, 03.09.2006
Monday, 04.09.2006
Tuesday, 05.09.2006
Wednesday, 06.09.2006

Citations should be made in the following way: Authors. Title. Eur Respir J 2006; 28: Suppl. 50, abstract number.

Material from 2006:

4395 Abstracts
610 Slide presentations
175 Webcasts
95 Handouts
175 Multimedia files

Material from 2006: Show

Novel treatments for asthma

Oral Presentation
Chairs: C. Page (London, United Kingdom), J. Lotvall (Gothenburg, Sweden)

Download all media

AER 001 effects on antigen challenge in atopic asthmatic subjects D. Wilbraham, R. Fuller (Berkeley, United States Of America; London, United Kingdom)
Pharmacological characterisation of indacaterol (QAB149), a novel once-daily inhaled β₂-agonist, on small airways in human and rat lung slices A. Trifilieff, P. J. Barnes, R. G. Sturton (Basel, Switzerland; London, United Kingdom)
PK/PD, safety and tolerability of a human anti-IL-1B monoclonal antibody (ACZ885) in healthy subjects J. Bonner, P. Lloyd, P. Lowe, G. Golor, R. Woessner, S. Pascoe (Horsham, United Kingdom; Berlin, Germany; Basel, Switzerland)
Impact of bronchial thermoplasty on asthma status: interim results from the AIR trial G. Cox, J. D. Miller, A. S. Rubin, P. Corris, N. C. Thomson, R. Niven, H. C. Sierstad, R. Olivenstein, I. Pavord, D. McCormack, M. Laviollette (Canada; Brazil; UK; Denmark)
Novel triple neurokinin receptors antagonist CS-003 strongly inhibits neurokinin related responses H. Tsuchida, S. Takahashi, E. Nosaka, O. Mukaiyama, K. Morimoto, M. Yamashita (Tokyo, Japan)
Preliminary evidence of bronchodilating activity of TPI 1020 (NO-budesonide) in humans B. O‘Connor, M. Armogida, A. Raza (London, United Kingdom; Sophia Antipolis, France)
A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma S. Pascoe, F. Kanniess, J. Bonner, P. Lloyd, P. Lowe, J. Beier, R. Woessner (Horsham, United Kingdom; Grosshansdorf, Wiesbaden, Germany; Basel, Switzerland)
Improving effect of fudosteine on sputum symptoms and health-related quality of life of patients with bronchial asthma H. Ohbayashi, K. Shimokata (Mizunami City, Nagoya City, Japan)